Loring Wolcott & Coolidge Fiduciary Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $203K | Sell |
522
-44
| -8% | -$17.1K | ﹤0.01% | 276 |
|
2025
Q1 | $242K | Hold |
566
| – | – | ﹤0.01% | 252 |
|
2024
Q4 | $233K | Hold |
566
| – | – | ﹤0.01% | 268 |
|
2024
Q3 | $237K | Buy |
566
+1
| +0.2% | +$419 | ﹤0.01% | 267 |
|
2024
Q2 | $313K | Buy |
565
+29
| +5% | +$16K | ﹤0.01% | 232 |
|
2024
Q1 | $285K | Buy |
536
+14
| +3% | +$7.45K | ﹤0.01% | 242 |
|
2023
Q4 | $258K | Sell |
522
-43
| -8% | -$21.2K | ﹤0.01% | 255 |
|
2023
Q3 | $255K | Buy |
565
+222
| +65% | +$100K | ﹤0.01% | 258 |
|
2023
Q2 | $152K | Buy |
343
+100
| +41% | +$44.4K | ﹤0.01% | 320 |
|
2023
Q1 | $112K | Buy |
243
+200
| +465% | +$92K | ﹤0.01% | 332 |
|
2022
Q4 | $22.1K | Sell |
43
-3
| -7% | -$1.54K | ﹤0.01% | 460 |
|
2022
Q3 | $21K | Hold |
46
| – | – | ﹤0.01% | 483 |
|
2022
Q2 | $22K | Buy |
+46
| New | +$22K | ﹤0.01% | 495 |
|
2021
Q3 | – | Sell |
-282
| Closed | -$108K | – | 806 |
|
2021
Q2 | $108K | Buy |
+282
| New | +$108K | ﹤0.01% | 391 |
|
2021
Q1 | – | Sell |
-182
| Closed | -$58K | – | 429 |
|
2020
Q4 | $58K | Buy |
+182
| New | +$58K | ﹤0.01% | 410 |
|
2019
Q4 | – | Sell |
-19
| Closed | -$5K | – | 678 |
|
2019
Q3 | $5K | Hold |
19
| – | – | ﹤0.01% | 608 |
|
2019
Q2 | $5K | Hold |
19
| – | – | ﹤0.01% | 609 |
|
2019
Q1 | $5K | Buy |
+19
| New | +$5K | ﹤0.01% | 592 |
|
2018
Q1 | – | Sell |
-106
| Closed | -$24K | – | 746 |
|
2017
Q4 | $24K | Hold |
106
| – | – | ﹤0.01% | 495 |
|
2017
Q3 | $20K | Buy |
106
+6
| +6% | +$1.13K | ﹤0.01% | 507 |
|
2017
Q2 | $19K | Hold |
100
| – | – | ﹤0.01% | 494 |
|
2017
Q1 | $17K | Hold |
100
| – | – | ﹤0.01% | 506 |
|
2016
Q4 | $14K | Hold |
100
| – | – | ﹤0.01% | 499 |
|
2016
Q3 | $13K | Hold |
100
| – | – | ﹤0.01% | 519 |
|
2016
Q2 | $13K | Buy |
+100
| New | +$13K | ﹤0.01% | 521 |
|